Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for renal protection in cardiac valve replacement under cardiopulmonary bypass
ChiCTR-TRC-14004832Phase 4Completed
- Sponsor
- The First Affiliated Hospital of USTC
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine in acute kidney failure (AKF) (2 arms), sponsored by The First Affiliated Hospital of USTC. Primary endpoints: Blood urea nitrogen, Serum creatinine concentration and 4 more. Started Jul 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on ChiCTR-TRC-14004832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004832.